NASDAQ$HCAT
Health Catalyst Inc · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Reported financial results, with revenue and Adjusted EBITDA beating the mid-point of quarterly guidance. Full year revenue and Adjusted EBITDA guidance were raised.
Health Catalyst reported total revenue of $73.2 million and Adjusted EBITDA of $3.5 million for the second quarter of 2023, exceeding the mid-point of their quarterly guidance. The company is raising its 2023 revenue and Adjusted EBITDA guidance and reiterating its full year 2023 bookings expectations.
- Total revenue reached $73.2 million.
- Adjusted EBITDA was $3.5 million.
- Full year revenue and Adjusted EBITDA guidance were raised.
- Full year 2023 bookings expectations were reiterated.
Headline financials
Revenue & EPS history
Health Catalyst · Revenue · Quarterly
$73.2M
Revenue by segment
Health Catalyst · $73.2M total across 2 segments · Q2 2023
- Technology$47.3M+4.2%64.6%
- Professional Services$25.9M+2.6%35.4%
Forward guidance
For the third quarter of 2023, Health Catalyst expects total revenue between $70.2 million and $74.2 million, and Adjusted EBITDA between $0.0 million and $2.5 million. For the full year of 2023, they expect total revenue between $290.5 million and $295.5 million, and Adjusted EBITDA between $10.0 million and $12.0 million.
Tailwinds
- Total revenue for Q3 2023 is expected to be between $70.2 million and $74.2 million.
- Adjusted EBITDA for Q3 2023 is expected to be between $0.0 million and $2.5 million.
- Total revenue for the full year 2023 is expected to be between $290.5 million and $295.5 million.
- Adjusted EBITDA for the full year 2023 is expected to be between $10.0 million and $12.0 million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2023
-3.1%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-4.0%
Avg return
30 days after
41%
11 / 27 earnings
Positive
+27.3%
Q2 2024
Best reaction
-36.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.9% | -21.7% | +4.6% | |
| Q4 2025 | -26.3% | -35.2% | -44.4% | |
| Q3 2025 | -5.6% | -20.5% | -10.2% | |
| Q1 2025 | +5.3% | +8.1% | +3.3% | |
| Q4 2024 | -11.1% | -8.5% | -7.9% | |
| Q3 2024 | +14.2% | +7.2% | +7.6% | |
| Q2 2024 | +27.3% | +7.3% | +22.9% | |
| Q1 2024 | -3.6% | +2.9% | -2.3% | |
| Q4 2023 | -14.7% | -8.9% | -14.4% | |
| Q3 2023 | +5.1% | -0.4% | +5.3% | |
| Q2 2023 | -8.0% | -5.0% | -12.4% | |
| Q1 2023 | -18.9% | -14.8% | -4.3% | |
| Q4 2022 | +7.3% | +5.8% | -14.8% | |
| Q3 2022 | +16.2% | +42.9% | +59.2% | |
| Q2 2022 | -36.6% | -34.7% | -35.9% | |
| Q1 2022 | -2.6% | +24.6% | +10.5% | |
| Q4 2021 | +1.5% | -7.1% | -3.7% | |
| Q3 2021 | -6.2% | -6.1% | -26.9% | |
| Q2 2021 | +1.5% | -2.3% | -2.8% | |
| Q1 2021 | -2.3% | -8.6% | -2.4% | |
| Q4 2020 | +0.6% | +0.1% | -2.1% | |
| Q3 2020 | -0.2% | -3.5% | +6.2% | |
| Q2 2020 | -7.2% | -10.9% | -3.4% | |
| Q1 2020 | -1.9% | -0.5% | -5.0% | |
| Q4 2019 | +1.3% | -5.8% | -20.1% | |
| Q3 2019 | +1.9% | -0.8% | -1.1% | |
| Q2 2019 | -11.5% | -7.8% | -13.1% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro